NAGE FY 2010 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$389M

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+31.0% YoY

Gross Profit

$3M38.9% margin

Operating Income

-$2M-26.7% margin

Net Income

-$2M-27.1% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$7M

Total Liabilities

$2M

Stockholders' Equity

$5M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6M	+31.0%
Gross Profit	$3M	$2M	+44.3%
Operating Income	-$2M	-$892,732	-126.0%
Net Income	-$2M	-$907,568	-126.1%